$APLM

Chen Hung-Wen purchased $3.5M of APLM

Chen Hung-Wen (Chief Executive Officer) purchased 270,000 shares of Apollomics Inc. (APLM) at an average of $13.15 ($12.00–$15.00, $3.55M total) across 2 trades on 2026-08-14.

Original reporting
SEC EDGAR · Chen Hung-Wen
Published Aug 17, 2026, 11:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$APLM
Bullish
medium confidence
Mentioned
$APLM
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$APLMBullishLow
01

Why it matters

The newest disclosed fact is the CEO’s open-market purchase totaling about $3.55M, with holdings after the transaction of 418,334 shares.

02

Market read

Traders may view the CEO’s buying as supportive sentiment, but the filing alone does not change fundamentals.

03

What to watch

The price range ($12 to $15) suggests execution across levels, but the article provides no context on prior insider activity, lockups, or whether the purchase was funded by sales elsewhere.

Relevance 7/10Novelty 5/10Timing: filed 2026-08-17, trades dated 2026-08-14

Background

This is an SEC Form 4 insider transaction for Apollomics Inc. (APLM) by CEO Chen Hung-Wen.

Company-level read

Ticker impact

$APLMBullishMedium confidence
Context

Apollomics CEO Chen Hung-Wen bought $3.55M of APLM shares in two trades at $12 and $15 on 2026-08-14.

Expected impact

Likely limited near-term impact; may support sentiment rather than drive a fundamental repricing.

Evidence & confidence

The filing is a primary Form 4 disclosure and the transaction size is meaningful, but there is no accompanying guidance, deal, or fundamental update in the text.

Market effects

No sector-wide implications stated; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider buying can be routine liquidity management or part of a broader compensation strategy, especially without a 10b5-1 plan.

Key entities

  • Apollomics Inc.

    Company whose shares were purchased by its CEO, disclosed via SEC Form 4.

  • Chen Hung-Wen

    CEO and director who executed the open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$APLMMedAI 8/10

Apollomics Announces $10 Million Private Placement; Stock Down

Apollomics Inc. (APLM) said it entered definitive subscription agreements for a roughly $10 million private placement. It includes cash subscriptions for 533,334 Class A shares at $15.00 (about $8.0 million) and conversion of a $2 million unsecured convertible note into 166,667 shares at $12.00. Closing is expected around Aug. 14, 2026. APLM shares were $18.16 Tuesday.

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).